A novel insertion mutation of acetazolamide-responsive episodic ataxia in a Japanese family.
We report a Japanese family with acetazolamide-responsive episodic ataxia. The proband was a 41-year-old woman with interictal nystagmus. She experienced recurrent attacks of loss of equilibrium and loss of coordination of the extremities accompanied by dysarthria and nausea beginning at about 10 years old. These episodes usually lasted for several hours two or three times a week. Direct sequence of CACNA1A demonstrated a novel insertion mutation in the patient and her father. This mutation is estimated to cause early stop of the gene transcription, producing a truncated protein. This is the first report of episodic ataxia type 2 of which the mutation was identified in a Japanese family.
Department of Neurology and Geriatrics, Gifu University, School of Medicine, Tsukasa-Machi, Gifu 500-8705, Japan. zmatsuya@cc.gifu-u.ac.jp
Zenjiro
Z
Matsuyama
Masahiko
M
Murase
Hirotaka
H
Shimizu
Yoko
Y
Aoki
Misato
M
Hayashi
Isao
I
Hozumi
Takashi
T
Inuzuka
D000086:Acetazolamide / Q000627:therapeutic use; D000328:Adult; D000595:Amino Acid Sequence; D000927:Anticonvulsants / Q000627:therapeutic use; D001483:Base Sequence; D015220:Calcium Channels / Q000235:genetics*; D002524:Cerebellar Ataxia / Q000188:drug therapy / Q000235:genetics*; D005091:Exons; D005192:Family Health; D005260:Female; D016368:Frameshift Mutation; D005820:Genetic Testing; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008297:Male; D008969:Molecular Sequence Data; D016254:Mutagenesis, Insertional; D009759:Nystagmus, Pathologic / Q000150:complications / Q000188:drug therapy; D010375:Pedigree; D016133:Polymerase Chain Reaction; D020864:Calcium Channels, N-Type
D000086:Acetazolamide; D000927:Anticonvulsants; D015220:Calcium Channels; C105656:CACNA1A protein, human; D020864:Calcium Channels, N-Type